MRI aspects of secondary progressive multiple sclerosis

Wolinsky JS Multiple sclerosis. In Current Neurology, 1993 Vol 13, ed. Appel SH. Chicago: Mosby-Year Book, Inc., pp 167-207.

Jacobs LD , Beck RW , Simon JH , et al. Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group. N Engl J Med2000; 343: 898-904.

Comi G. , Filippi M. , Barkhof F. , et al. Effect of early interferon treatment on conversion to definite multiple sclerosis: A randomised study. Lancet2001; 357: 1576-1582.

Lublin FD , Reingold SC Defining the clinical course of multiple sclerosis: Results of an international survey. Neurology1996; 46: 907-911.

Whitaker JN , Kachelhofer RD , Bradley EL , et al. Urinary myelin basic protein-like material as a correlate of the progression of multiple sclerosis. Ann Neurol1995; 38: 625-632.

Beck RW , Cleary PA , Trobe JD , et al. The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group . New Engl J Med1993; 329: 1764-1769.

Filippi M. , Horsfield MA , Morrissey SP , et al. Quantitative brain MRI lesion load predicts the course of clinically isolated syndromes suggestive of multiple sclerosis. Neurology1994; 44: 635-641.

Noseworthy JH , Wolinsky JS , Lublin FD , et al. Linomide in relapsing and secondary progressive MS: Trial design and clinical results . Neurology2000; 54: 1726-1733.

Wolinsky JS , Narayana PA , Noseworthy JH , et al. Linomide in relapsing and secondary progressive MS: MRI results . Neurology2000; 54: 1734-1741.

European Study Group on interferon beta-1b in secondary progressive MS. Placebo-controlled multicentre randomised trial of interferon beta-1b in treatment of secondary progressive multiple sclerosis. Lancet1998; 352: 1491-1497.

Secondary Progressive Efficacy Clinical Trial of Recombinant Interferon-beta-1a in MS (SPECTRIMS) Study Group. Randomized controlled trial of interferon-beta-1a in secondary progressive MS: Clinical results. Neurology2001; 56: 1496-1504.

Kappos L. , Moeri D. , Radue EW , et al. Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: A meta-analysis. Lancet1999; 353: 964-969.

Van Walderveen Maa , Lycklama a Nijeholt GJ , Ader HJ , et al. Hypointense lesions on T1-weighted spin-echo magnetic resonance imaging—Relation to clinical characteristics in subgroups of patients with multiple sclerosis . Arch Neurol2001; 58: 76-81.

van Walderveen MA , Kamphorst W. , Scheltens P. , et al. Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis. Neurology1998; 50: 1282-1288.

van Waesberghe JH , van Walderveen MA , Castelijns JA , et al. Patterns of lesion development in multiple sclerosis: Longitudinal observations with T1-weighted spin-echo and magnetization transfer MR. AJNR1998; 19: 675-683.

Filippi M. , Rovaris M. , Rocca MA , Sormani MP , Wolinsky JS , Comi G. , et al. Glatiramer acetate reduces the proportion of new MS lesions evolving into 'black holes'. Neurology2001 ; (in press).

Filippi M. , Wolinsky JS , Sormani MP , Comi G. , et al. Enhancement frequency decreases with increasing age in relapsing-remitting multiple sclerosis. Neurology2001; 56: 422-423.

Goodkin DE , Rooney WD , Sloan R. , et al. A serial study of new MS lesions and the white matter from which they arise. Neurology1998; 51: 1689-1697.

Silver NC , Tofts PS , Symms MR , Barker GJ , Thompson AJ , Miller DH Quantitative contrast-enhanced magnetic resonance imaging to evaluate blood-brain barrier integrity in multiple sclerosis: A preliminary study. Multiple Sclerosis2001; 7: 75-82.

McGowan JC , Filippi M. , Campi A. , Grossman RI Magnetisation transfer imaging: Theory and application to multiple sclerosis . J Neurol Neurosurg Psych1998; 64(Suppl 1): S66-S69.

Richert ND , Ostuni JL , Bash CN , Leist TP , McFarland HF , Frank JA Interferon beta-1b and intravenous methylprednisolone promote lesion recovery in multiple sclerosis. Multiple Sclerosis2001; 7: 49-58.

Filippi M. , Iannucci G. , Tortorella C. , et al. Comparison of MS clinical phenotypes using conventional and magnetization transfer MRI. Neurology1999 ; 52: 588-594.

Rocca MA , Mastronardo G. , Rodegher M. , Comi G. , Filippi M. Long-term changes of magnetization transfer-derived measures from patients with relapsing-remitting and secondary progressive multiple sclerosis . AJNR1999; 20: 821-827.